Skip to Content

APO R4.5 (Rivastigmine Tartrate 4.5 mg)

Pill with imprint APO R4.5 is Red, Capsule-shape and has been identified as Rivastigmine Tartrate 4.5 mg. It is supplied by Apotex Corp..

Rivastigmine is used in the treatment of parkinson's disease; alzheimer's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 4.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO R4.5

Rivastigmine tartrate 4.5 mg APO R4.5
Rivastigmine tartrate 4.5 mg APO R4.5
Rivastigmine tartrate 4.5 mg APO R4.5
Rivastigmine tartrate 4.5 mg APO R4.5

Rivastigmine Tartrate

Imprint
APO R4.5
Strength
4.5 mg
Color
Red
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Apotex Corp.
National Drug Code (NDC)
60505-3222

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.